Welcome to LookChem.com Sign In|Join Free

CAS

  • or

401909-15-7

Benzenemethanamine, 4-amino-2,5-difluoro- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

401909-15-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 401909-15-7 Structure

  • Basic information

    1. Product Name: Benzenemethanamine, 4-amino-2,5-difluoro- (9CI)
    2. Synonyms: Benzenemethanamine, 4-amino-2,5-difluoro- (9CI)
    3. CAS NO:401909-15-7
    4. Molecular Formula: C7H8F2N2
    5. Molecular Weight: 158.1486264
    6. EINECS: N/A
    7. Product Categories: HALIDE
    8. Mol File: 401909-15-7.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 244.8±35.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.316±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 8.97±0.10(Predicted)
    10. CAS DataBase Reference: Benzenemethanamine, 4-amino-2,5-difluoro- (9CI)(CAS DataBase Reference)
    11. NIST Chemistry Reference: Benzenemethanamine, 4-amino-2,5-difluoro- (9CI)(401909-15-7)
    12. EPA Substance Registry System: Benzenemethanamine, 4-amino-2,5-difluoro- (9CI)(401909-15-7)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 401909-15-7(Hazardous Substances Data)

401909-15-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 401909-15-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,1,9,0 and 9 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 401909-15:
(8*4)+(7*0)+(6*1)+(5*9)+(4*0)+(3*9)+(2*1)+(1*5)=117
117 % 10 = 7
So 401909-15-7 is a valid CAS Registry Number.

401909-15-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(aminomethyl)-2,5-difluoroaniline

1.2 Other means of identification

Product number -
Other names BENZENEMETHANAMINE,4-AMINO-2,5-DIFLUORO

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:401909-15-7 SDS

401909-15-7Upstream product

401909-15-7Downstream Products

401909-15-7Relevant articles and documents

TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITORS

-

Page/Page column 58-59; 67, (2021/01/29)

The present invention relates to novel tricyclic compounds that are AKR1C3 dependent KARS inhibitor, processes for their preparation, pharmaceutical compositions, and medicaments containing them, and their use in diseases and disorders mediated by an AKR1C3 dependent KARS inhibitor.

Novel thiourea derivatives and the pharmaceutical compositions containing the same

-

, (2008/06/13)

The present invention relates to novel thiourca derivatives as a modulator for vanilloid receptor (VR) and the phar- maceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pain, chronic pain, neuropathic pain, post-operative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurodegeneration, neurotic skin disorder, stroke, urinary bladder hypersensitiveness, irritable bowel syndrome, a respiratory disorder such as asthma or chronic obstructive pulmonary disease, irritation of skin, eye or mucous membrane, fervescence, stomach-duodenal ulcer, inflam- matory bowel disease and inflammatory diseases can be enumerated. The present invention provides a pharmaceutical composition for prevention or treatment of these diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 401909-15-7